News Daily News AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER L.A. McKeown July 30, 2025
News Conference News AHA 2024 Two Trials Provide Insights Into Catheter Ablation Options for Persistent AF Todd Neale November 21, 2024
News Conference News HFSA 2024 EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER Caitlin E. Cox October 03, 2024
News Daily News Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial Todd Neale September 30, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Conference News Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women Yael L. Maxwell May 09, 2024
News Conference News EHRA 2023 Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry Michael O'Riordan April 25, 2023
News Conference News EHRA 2023 ‘Marshall Plan’ Ablation Superior to Pulmonary Vein Isolation in Persistent AF Michael O'Riordan April 20, 2023
News Daily News Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes Yael L. Maxwell December 06, 2022
News Conference News AHA 2022 Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link L.A. McKeown November 01, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2022 Todd Neale August 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022